CANCER INSURANCE with TGen
Hospital Indemnity Insurance Explained
Precision Care™ Cancer Insurance
Precision Care™ Cancer Insurance is designed to help policyholders faced with a cancer diagnosis afford and have access to groundbreaking treatment advancements which may not be covered by other insurance. Precision Care™ gives Policyholders access to TGen’s world class Cancer Physicians and to TGen’s cutting-edge genomic sequencing services while providing cash to pay for these services and the high costs of today’s specialized cancer treatments.
​
-
Lump sum benefit paid directly to you upon diagnosis of cancer, heart attack and stroke
-
Benefit amounts from $10,000 to $75,000 (in increments of $5,000)
-
Reoccurrence Benefits starting after only one year
-
Heart Attack and Stroke Rider
-
Therapy and Wellness Rider
-
Intensive Care Ride
-
Return of Premium Rider
-
Individual, single parent, couple and family coverage available
What is Precision Care?
Precision Care™ Cancer Insurance is designed to help policyholders faced with a cancer diagnosis afford and have access to groundbreaking treatment advancements which may not be covered by other insurance. Precision Care™ gives Policyholders access to TGen’s world class Cancer Physicians and to TGen’s cutting-edge genomic sequencing services while providing cash to pay for these services and the high costs of today’s specialized cancer treatments. For more information on Precision Care™, visit: outsmartmycancer.com.
How does genome sequencing work?
-
Should you be diagnosed with cancer, a biopsy is taken of your tumor. Tumor tissue and blood are isolated and extracted and your DNA is sequenced in TGen’s laboratories.
-
Using highly sophisticated equipment, the sequenced genetic profile is scanned for abnormalities that dictate the tumor functions.
-
The abnormalities are analyzed to determine whether they match known mutations that may have responded to particular therapies and may uncover a potential treatment option not previously considered.
-
If there’s a match, doctors may be able to use the findings to suggest specific treatments that have been used in the past to target the same mutations.
Who is TGen?
TGen, the Translational Genomics Research Institute, is an affiliate of City of Hope and is a nonprofit medical research institute. TGen conducts groundbreaking research that unravels the genetic components of common and complex diseases for life-changing results. TGen’s internationally-recognized experts are innovators in clinical genomic testing and pioneers in precision medicine. Their genomic testing explores a patient’s genomic uniqueness in ways unimaginable just a few short years ago. This research helps them set a course of treatment that may not be right for everyone...but is just right for you. For more information on TGen, visit: www.tgen.org.
About TGen
Click Here!
To Play
GTL's TGEN Cancer Policy
GTL Cancer Policy
Click Here!
